Blue Fin Capital’s Idexx Laboratories IDXX Stock Holding History

Blue Fin Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276K	Buy	+525	New	+$294K	0.04%	147

Other funds holding IDXX

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Blue Fin Capital's IDXX Position: Q2 2026 in Review

Blue Fin Capital opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 525 shares worth $276K. The stake represents 0.04% of the portfolio and ranks #147 among its holdings.

572 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Blue Fin Capital held 525 shares of Idexx Laboratories worth $276K as of Q2 2026.
Idexx Laboratories was a new Blue Fin Capital position in Q2 2026.
Idexx Laboratories made up 0.04% of Blue Fin Capital's portfolio in Q2 2026, its #147 holding.
572 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Blue Fin Capital's 13F filing for Q2 2026, filed 4 Aug 2026.